July 31 (Reuters) - Mettler-Toledo International ( MTD )

raised its profit forecast for the year on Thursday, after

posting better-than-expected second-quarter results, driven by

strong demand for its laboratory instruments used in drug

development.

The Columbus, Ohio-based company forecast 2025 adjusted

profit in the range of $42.10 to $42.60 per share, compared with

its previous projection of $41.25 to $42. Analysts were

expecting a profit of $41.60 per share, according to data

compiled by LSEG.

The company said its full-year forecast accounts for a 4%

impact from earlier shipping delays and an additional 4% drag

from higher tariffs, although it expects most of the tariff

costs to be offset by mitigation efforts this year.

Mettler-Toledo ( MTD ) also said that it was now expecting

third-quarter adjusted profit in the range of $10.55 to $10.75

per share, compared with estimates of $10.47 apiece.

The firm's second-quarter sales came in at $983.22 million,

surpassing analysts' estimate of $957.9 million.

On an adjusted basis, Mettler-Toledo ( MTD ) earned a profit of

$10.09 per share for the quarter ending June 30, topping

analysts' estimates of $9.61 each.

The company designs and produces precision instruments,

including laboratory balances, industrial scales, analytical

instruments, and product inspection systems, which are used

across sectors like pharmaceuticals, food processing, and

chemicals.

(Reporting by Padmanabhan Ananthan in Bengaluru; Editing by

Anil D'Silva)